Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Apr 2007 07:01

ViaLogy PLC18 April 2007 Date: 18 April 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") For Immediate Release ViaLogy PLC Board Appointment LONDON, April 18, 2007 -- ViaLogy PLC (LSE: VIY), the AIM-quoted technologycompany, today announced the appointment of Mr. Shah Talukder as executivedirector of ViaLogy with immediate effect. In addition to his appointment tothe main Board, Mr Talukder has also been appointed President and ChiefExecutive Officer of ViaLogy's wholly-owned American subsidiary, ViaLogy LLC, ofPasadena, California. Mr. Talukder comes to ViaLogy from Cisco Systems, where he was General Managerof Cisco's Safety, Security and Systems Business Unit (S3BU) where heestablished a start-up culture. Within Cisco he developed the vision,strategy, and road map for the Interoperability and Collaboration System (IPICS)family of products and applications. The system enables personnel within thesame or different agencies to communicate across previously isolated radio, IPand non-IP networks by delivering information to various types of communicationsdevices. These could range from a radio, a telephone, and an IP phone to amobile phone and a computer. At Cisco, Mr. Talukder was also instrumental in working closely with customers,industry and technology leaders, research institutions and sensor vendors todefine a vision and strategy for the Sensor Policy Manager (SPM) as a frameworkfor sensor based rapid detection and response to greatly improve the quality andspeed of information dissemination. "I am very excited at the potential of ViaLogy and I am looking forward toleading and growing the team," said Mr. Talukder. "The breadth of technologiesdeveloped by the company is extremely impressive and has a wide range ofapplications. It has the potential to become a platform for sensor and networksub-system interoperability and provide a service delivery architecture based oncustomer specific needs in such areas as Enterprise Security and Operations,Defence, Connected Real Estate, Oil and Gas, Transportation, Home Land Security,Retail and Healthcare." Mr Talukder added: "Customers and industry at large are looking for scaleablesolutions to sensor based remote monitoring, emissions mitigation, greenenvironment, physical and border security. As an example customers globally,regardless of national boundaries, whom I have met and spoken to are keenlyinterested in enhancing their capabilities to remotely monitor and respond togreenhouse gas, seismic and motion sensors, biological agents or to detectpressure in oil or gas pipelines. They want to provide the appropriateinformation within seconds, based on policy and business rules governing theincident. The information could be send to specific PC laptops, cell phones,PDAs, IP Phones, TV or digital signage etc. and could be in the form ofstandards-based video, voice and sensor data". "We are delighted that Shah Talukder has agreed to join us," said Mr. MichaelKelly, the former banker and venture capitalist who spearheaded the mergerarrangements which gave ViaLogy a public quotation on the AIM last year. "At Cisco, Shah has built, managed, and mentored teams towards industryexcellence through product innovations and delivery of solutions and has createda start-up like culture which is reflected by the wide industry acceptance ofCisco IPICS." Mr. Kelly will remain on the board of ViaLogy PLC as a non-executive director. ViaLogy PLC's Chairman, Mr. Terry Bond, stated: "During the last five yearsViaLogy has successfully developed a range of network-centric, real-time signalprocessing technology platforms for sensor applications. We are now transformingViaLogy into a product and sales centric company. Shah Talukder is the idealperson to scale and develop the vision, strategy and focused execution needed tolead ViaLogy forward". For further information please contact: ViaLogy PLCTerry Bond, Chairman - ViaLogy PLC +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy / Liam O'Donoghue +44 (0)20 7107 8000 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defence andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.